Narinder Pal Bhalla insider trades

Open-market stock purchases and sales by Narinder Pal Bhalla, Chief Medical Officer at Lexeo Therapeutics, Inc, from SEC Form 4 filings since Feb 13, 2026.

Recent trades

DateStockTradeValue
Sep 24, 2026LXEO Lexeo Therapeutics, IncBought (not open market)—
Sep 14, 2026LXEO Lexeo Therapeutics, IncBought (not open market)$9.7K
Feb 13, 2026LXEO Lexeo Therapeutics, IncBought (not open market)—
Feb 13, 2026LXEO Lexeo Therapeutics, IncBought (not open market)—

Companies traded

  • LXEO Lexeo Therapeutics, Inc: other filings, last Sep 24, 2026

Get free alerts when Narinder Pal Bhalla files a new trade →